Bourdon David 4
4 · LifeStance Health Group, Inc. · Filed Mar 12, 2024
Insider Transaction Report
Form 4
Bourdon David
DirectorChief Executive Officer
Transactions
- Award
Common Stock
2024-03-08+104,022→ 368,038 total - Award
Common Stock
2024-03-08+124,644→ 492,682 total - Sale
Common Stock
2024-03-11$6.93/sh−58,826$407,664→ 433,856 total
Footnotes (3)
- [F1]Includes 104,022 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F2]Represents performance-based restricted stock units previously granted to the Reporting Person, which vested on March 8, 2024.
- [F3]Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.